| 1.4 |
5.7 |
GO:0055099 |
response to high density lipoprotein particle(GO:0055099) |
| 0.8 |
1.5 |
GO:0032877 |
positive regulation of DNA endoreduplication(GO:0032877) |
| 0.7 |
4.5 |
GO:0003383 |
apical constriction(GO:0003383) |
| 0.7 |
2.0 |
GO:0060598 |
dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
| 0.6 |
3.0 |
GO:0070345 |
negative regulation of fat cell proliferation(GO:0070345) |
| 0.6 |
2.3 |
GO:0060032 |
notochord regression(GO:0060032) |
| 0.6 |
1.1 |
GO:0071930 |
negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 0.5 |
1.4 |
GO:0071649 |
regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) |
| 0.5 |
1.4 |
GO:0046671 |
negative regulation of retinal cell programmed cell death(GO:0046671) |
| 0.4 |
1.7 |
GO:0046210 |
nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
| 0.4 |
4.1 |
GO:0016127 |
cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.4 |
1.6 |
GO:0006842 |
tricarboxylic acid transport(GO:0006842) succinate transport(GO:0015744) citrate transport(GO:0015746) |
| 0.4 |
1.1 |
GO:0060023 |
soft palate development(GO:0060023) |
| 0.4 |
1.5 |
GO:0032901 |
positive regulation of neurotrophin production(GO:0032901) |
| 0.3 |
1.3 |
GO:0042276 |
error-prone translesion synthesis(GO:0042276) |
| 0.3 |
1.5 |
GO:0010032 |
meiotic chromosome condensation(GO:0010032) |
| 0.3 |
0.9 |
GO:0035021 |
negative regulation of Rac protein signal transduction(GO:0035021) glutamate secretion, neurotransmission(GO:0061535) |
| 0.3 |
0.9 |
GO:0014826 |
vein smooth muscle contraction(GO:0014826) |
| 0.3 |
2.8 |
GO:0051574 |
positive regulation of histone H3-K9 methylation(GO:0051574) |
| 0.3 |
1.1 |
GO:0021775 |
smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
| 0.3 |
2.2 |
GO:0071557 |
histone H3-K27 demethylation(GO:0071557) |
| 0.3 |
1.6 |
GO:0002934 |
desmosome organization(GO:0002934) |
| 0.3 |
2.1 |
GO:0070493 |
thrombin receptor signaling pathway(GO:0070493) |
| 0.3 |
1.0 |
GO:0003150 |
muscular septum morphogenesis(GO:0003150) |
| 0.3 |
1.3 |
GO:0001561 |
fatty acid alpha-oxidation(GO:0001561) |
| 0.2 |
1.2 |
GO:0006167 |
AMP biosynthetic process(GO:0006167) |
| 0.2 |
1.0 |
GO:2001032 |
regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
| 0.2 |
2.4 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.2 |
0.2 |
GO:2000224 |
testosterone biosynthetic process(GO:0061370) regulation of testosterone biosynthetic process(GO:2000224) |
| 0.2 |
0.7 |
GO:0035621 |
ER to Golgi ceramide transport(GO:0035621) ceramide transport(GO:0035627) |
| 0.2 |
4.5 |
GO:0090005 |
negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
| 0.2 |
1.1 |
GO:0060178 |
regulation of exocyst localization(GO:0060178) |
| 0.2 |
0.9 |
GO:0033326 |
cerebrospinal fluid secretion(GO:0033326) |
| 0.2 |
0.7 |
GO:0003195 |
tricuspid valve development(GO:0003175) tricuspid valve morphogenesis(GO:0003186) tricuspid valve formation(GO:0003195) right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 0.2 |
1.1 |
GO:0051697 |
protein delipidation(GO:0051697) |
| 0.2 |
0.6 |
GO:0048211 |
Golgi vesicle docking(GO:0048211) |
| 0.2 |
0.6 |
GO:0021893 |
cerebral cortex GABAergic interneuron fate commitment(GO:0021893) |
| 0.2 |
0.8 |
GO:0000707 |
meiotic DNA recombinase assembly(GO:0000707) resolution of recombination intermediates(GO:0071139) |
| 0.2 |
1.5 |
GO:0035881 |
amacrine cell differentiation(GO:0035881) |
| 0.2 |
0.8 |
GO:0046552 |
eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
| 0.2 |
0.8 |
GO:0016340 |
calcium-dependent cell-matrix adhesion(GO:0016340) |
| 0.2 |
0.8 |
GO:0051684 |
maintenance of Golgi location(GO:0051684) |
| 0.2 |
0.5 |
GO:0070103 |
interleukin-4-mediated signaling pathway(GO:0035771) tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) regulation of interleukin-6-mediated signaling pathway(GO:0070103) negative regulation of interleukin-6-mediated signaling pathway(GO:0070104) |
| 0.2 |
1.0 |
GO:0036233 |
glycine import(GO:0036233) |
| 0.1 |
0.7 |
GO:0060838 |
lymphatic endothelial cell fate commitment(GO:0060838) regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
| 0.1 |
1.0 |
GO:0035726 |
common myeloid progenitor cell proliferation(GO:0035726) |
| 0.1 |
1.5 |
GO:0070307 |
lens fiber cell development(GO:0070307) |
| 0.1 |
1.9 |
GO:0034501 |
protein localization to kinetochore(GO:0034501) |
| 0.1 |
0.9 |
GO:2000042 |
negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
| 0.1 |
1.0 |
GO:2000301 |
myeloid progenitor cell differentiation(GO:0002318) negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 0.1 |
1.0 |
GO:0051608 |
histamine transport(GO:0051608) |
| 0.1 |
0.6 |
GO:0050862 |
positive regulation of T cell receptor signaling pathway(GO:0050862) |
| 0.1 |
0.5 |
GO:0035553 |
oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
| 0.1 |
0.5 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 0.1 |
0.6 |
GO:0016266 |
O-glycan processing(GO:0016266) |
| 0.1 |
1.4 |
GO:0045723 |
positive regulation of fatty acid biosynthetic process(GO:0045723) |
| 0.1 |
1.0 |
GO:0010587 |
miRNA catabolic process(GO:0010587) |
| 0.1 |
0.4 |
GO:0003192 |
mitral valve formation(GO:0003192) condensed mesenchymal cell proliferation(GO:0072137) |
| 0.1 |
0.8 |
GO:1900194 |
negative regulation of oocyte maturation(GO:1900194) |
| 0.1 |
2.2 |
GO:0038092 |
nodal signaling pathway(GO:0038092) |
| 0.1 |
0.4 |
GO:0046487 |
glyoxylate metabolic process(GO:0046487) |
| 0.1 |
1.9 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
| 0.1 |
0.4 |
GO:0060836 |
lymphatic endothelial cell differentiation(GO:0060836) |
| 0.1 |
1.1 |
GO:0021521 |
ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 0.1 |
0.4 |
GO:0006545 |
glycine biosynthetic process(GO:0006545) |
| 0.1 |
0.4 |
GO:0048633 |
positive regulation of skeletal muscle tissue growth(GO:0048633) |
| 0.1 |
0.4 |
GO:0097428 |
protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.1 |
0.7 |
GO:0061687 |
detoxification of inorganic compound(GO:0061687) |
| 0.1 |
0.9 |
GO:0043568 |
positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.1 |
0.3 |
GO:0010288 |
response to lead ion(GO:0010288) |
| 0.1 |
0.9 |
GO:0051967 |
negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.1 |
0.3 |
GO:1903265 |
positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.1 |
0.7 |
GO:0098535 |
de novo centriole assembly(GO:0098535) |
| 0.1 |
0.3 |
GO:1902608 |
regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
| 0.1 |
1.5 |
GO:0035024 |
negative regulation of Rho protein signal transduction(GO:0035024) |
| 0.1 |
0.5 |
GO:0009449 |
gamma-aminobutyric acid biosynthetic process(GO:0009449) |
| 0.1 |
1.7 |
GO:0048266 |
behavioral response to pain(GO:0048266) |
| 0.1 |
1.4 |
GO:0048873 |
homeostasis of number of cells within a tissue(GO:0048873) |
| 0.1 |
0.1 |
GO:0048859 |
formation of anatomical boundary(GO:0048859) |
| 0.1 |
1.0 |
GO:0033234 |
negative regulation of protein sumoylation(GO:0033234) |
| 0.1 |
0.7 |
GO:0010571 |
positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.1 |
0.3 |
GO:2001013 |
epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.1 |
0.8 |
GO:0014842 |
regulation of skeletal muscle satellite cell proliferation(GO:0014842) positive regulation of myoblast proliferation(GO:2000288) |
| 0.1 |
1.2 |
GO:0030220 |
platelet formation(GO:0030220) platelet morphogenesis(GO:0036344) |
| 0.1 |
0.7 |
GO:0090435 |
protein localization to nuclear envelope(GO:0090435) |
| 0.1 |
0.2 |
GO:0097402 |
neuroblast migration(GO:0097402) |
| 0.1 |
0.1 |
GO:0045472 |
response to ether(GO:0045472) |
| 0.1 |
0.6 |
GO:0030513 |
positive regulation of BMP signaling pathway(GO:0030513) |
| 0.1 |
0.2 |
GO:0038108 |
negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
| 0.1 |
1.2 |
GO:0035873 |
lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
| 0.1 |
0.2 |
GO:2000383 |
regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
| 0.1 |
0.9 |
GO:0071378 |
growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
| 0.1 |
0.6 |
GO:0034773 |
histone H4-K20 trimethylation(GO:0034773) |
| 0.1 |
3.4 |
GO:0045669 |
positive regulation of osteoblast differentiation(GO:0045669) |
| 0.0 |
0.3 |
GO:0007168 |
receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.0 |
0.3 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 0.0 |
0.1 |
GO:0010726 |
positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
| 0.0 |
0.2 |
GO:0044829 |
positive regulation by host of viral genome replication(GO:0044829) |
| 0.0 |
0.1 |
GO:0046881 |
positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
| 0.0 |
2.0 |
GO:0048843 |
negative regulation of axon extension involved in axon guidance(GO:0048843) |
| 0.0 |
2.1 |
GO:1901998 |
toxin transport(GO:1901998) |
| 0.0 |
2.1 |
GO:0070527 |
platelet aggregation(GO:0070527) |
| 0.0 |
0.2 |
GO:0021914 |
negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
| 0.0 |
0.2 |
GO:0032911 |
neurotrophin production(GO:0032898) nerve growth factor production(GO:0032902) negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.0 |
0.1 |
GO:0030167 |
proteoglycan catabolic process(GO:0030167) |
| 0.0 |
0.3 |
GO:0061732 |
mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.0 |
1.1 |
GO:0060351 |
cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
| 0.0 |
0.7 |
GO:0071425 |
hematopoietic stem cell proliferation(GO:0071425) |
| 0.0 |
0.5 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 0.0 |
0.4 |
GO:0007250 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.0 |
0.5 |
GO:0060134 |
prepulse inhibition(GO:0060134) |
| 0.0 |
0.1 |
GO:0010808 |
positive regulation of synaptic vesicle priming(GO:0010808) |
| 0.0 |
0.7 |
GO:0097352 |
autophagosome maturation(GO:0097352) |
| 0.0 |
0.9 |
GO:0046856 |
phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.0 |
0.2 |
GO:0035428 |
hexose transmembrane transport(GO:0035428) |
| 0.0 |
0.2 |
GO:0070986 |
left/right axis specification(GO:0070986) |
| 0.0 |
0.3 |
GO:0019800 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.0 |
0.6 |
GO:0019430 |
removal of superoxide radicals(GO:0019430) |
| 0.0 |
0.4 |
GO:2000193 |
positive regulation of fatty acid transport(GO:2000193) |
| 0.0 |
0.3 |
GO:0006977 |
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
| 0.0 |
0.1 |
GO:0090219 |
negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) negative regulation of lipid kinase activity(GO:0090219) |
| 0.0 |
0.1 |
GO:2000271 |
positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.0 |
1.8 |
GO:0006970 |
response to osmotic stress(GO:0006970) |
| 0.0 |
0.5 |
GO:1902043 |
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
| 0.0 |
0.9 |
GO:0015804 |
neutral amino acid transport(GO:0015804) |
| 0.0 |
1.0 |
GO:0045670 |
regulation of osteoclast differentiation(GO:0045670) |
| 0.0 |
0.2 |
GO:0030388 |
fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.0 |
0.5 |
GO:0001913 |
T cell mediated cytotoxicity(GO:0001913) |
| 0.0 |
0.4 |
GO:0090129 |
positive regulation of synapse maturation(GO:0090129) |
| 0.0 |
1.1 |
GO:0030835 |
negative regulation of actin filament depolymerization(GO:0030835) |
| 0.0 |
0.1 |
GO:0070375 |
ERK5 cascade(GO:0070375) |
| 0.0 |
0.8 |
GO:0032835 |
glomerulus development(GO:0032835) |
| 0.0 |
1.0 |
GO:0010501 |
RNA secondary structure unwinding(GO:0010501) |
| 0.0 |
0.6 |
GO:0048025 |
negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
| 0.0 |
0.3 |
GO:1901741 |
positive regulation of myoblast fusion(GO:1901741) |
| 0.0 |
0.4 |
GO:0006767 |
water-soluble vitamin metabolic process(GO:0006767) |
| 0.0 |
0.3 |
GO:0032957 |
inositol trisphosphate metabolic process(GO:0032957) |
| 0.0 |
0.7 |
GO:0030514 |
negative regulation of BMP signaling pathway(GO:0030514) |
| 0.0 |
0.0 |
GO:0007521 |
muscle cell fate determination(GO:0007521) |
| 0.0 |
0.2 |
GO:0014898 |
muscle hypertrophy in response to stress(GO:0003299) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 0.0 |
0.3 |
GO:2000369 |
regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.0 |
0.1 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
| 0.0 |
0.5 |
GO:0034243 |
regulation of transcription elongation from RNA polymerase II promoter(GO:0034243) |
| 0.0 |
0.7 |
GO:0000271 |
polysaccharide biosynthetic process(GO:0000271) |
| 0.0 |
0.4 |
GO:0050435 |
beta-amyloid metabolic process(GO:0050435) |
| 0.0 |
0.8 |
GO:0032088 |
negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
| 0.0 |
0.8 |
GO:0033138 |
positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
| 0.0 |
0.2 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
| 0.0 |
0.8 |
GO:0070936 |
protein K48-linked ubiquitination(GO:0070936) |
| 0.0 |
0.1 |
GO:0006362 |
transcription elongation from RNA polymerase I promoter(GO:0006362) |
| 0.0 |
1.1 |
GO:0051225 |
spindle assembly(GO:0051225) |
| 0.0 |
0.3 |
GO:0045494 |
photoreceptor cell maintenance(GO:0045494) |
| 0.0 |
0.3 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.0 |
0.5 |
GO:1902017 |
regulation of cilium assembly(GO:1902017) |
| 0.0 |
0.1 |
GO:2000254 |
regulation of male germ cell proliferation(GO:2000254) |
| 0.0 |
0.2 |
GO:0042462 |
eye photoreceptor cell development(GO:0042462) |
| 0.0 |
3.0 |
GO:0006631 |
fatty acid metabolic process(GO:0006631) |
